baber/WOPTO huggingface dataset:
Patent AT-E230239-T1 (AT)
Inventor: DITTEL RUDOLF H
IPC: A61B5/00
Filed: 1999-02-22
Granted: 2003-01-15
Abstract: The invention relates to a determination system for the direct qualitative and quantitative, almost immediate, highly specific, non-invasive detection of substances contained in the blood through measurement of spectral signatures. According to the invention, part of the device is gently pressed against the skin surface. The inventive system uses elements with optical properties according to the principle of attenuated total reflection.
Patent AT-E447542-T1 (AT)
Inventor: NAKAHARA KATSUMASA
IPC: B41M5/00
Filed: 1999-06-10
Granted: 2009-11-15
Abstract: It is an object of the present invention to obtain a composite sol capable of forming an ink-receiving layer having a high transparency and a high property for fixing dyes. The present invention provides a sol which is a colloidal solution having aggregate particles containing silica and alumina dispersed in an aqueous medium, wherein the silica is such that the primary particles are spherical and the average particle size of the primary particles is from 2 to 200 nm, the average particle size of the aggregate particles is at least twice the average particle size of the silica primary particles and at most 1,000nm, the  zeta -potential of the aggregate particles is at least +10 mV, and the pH of the solution is from 3 to 9. The present invention provides a method for producing a silica-alumina composite sol, which comprises gradually adding an aluminum salt of which the liquid exhibits acidity when dissolved in water, to a silica sol, and a method for producing a silica-alumina composite sol, which comprises mixing a silica sol with an alumina sol having a specific surface area of a xerogel obtainable by drying of at least 150 m<2>/g, to form aggregate particles containing silica and alumina, followed by peptization treatment.
Patent AT-E321872-T1 (AT)
Inventor: DRAPER JOHN
IPC: C07K14/415
Filed: 1999-06-21
Granted: 2006-04-15
Abstract: The present invention relates to inductible promoters for use in the control of heterologous genes in transformed plants. Suitable inducible promoters art those which are responsive to low levels of an environmentally acceptable and non-phytoxic inducing agent, and which also demonstrates a low level of developmentally or environmentally induced expression. A preferred prompter naturally drives the expression of a 21.3 kDa protein in Asparagus officinalis or an equivalent protein from the Lillaceae or Amaryllidaceae families. Under the control of a promoter of the invention, a gene will be expressed upon induction by SA or BTH, but preferably will not be developmentally expressed, systemically activated upon pathogen infection, or in response to ABA, ethylene, oxidative or osmotic stresses, or wounding.
Patent AT-E425697-T1 (AT)
Inventor: GUMBRECHT WALTER
IPC: G01N27/26
Filed: 1999-06-02
Granted: 2009-04-15
Abstract: The calibration fluid is composed of a biocompatible electrolyte that, at 37° C., exhibits a concentration of bicarbonate ions that lies in the normal physiological range of the concentration of the bicarbonate ions of the blood, exhibits a pH value that lies within a pH value range within 2 through 13 containing the value 7.41 and has a specific ionic strength. In order to enable a calibration of the sensor with a higher precision compared to a known calibration fluid of this type both in vivo as well as in vitro, the ionic strength of the fluid at 37° C. is selected such that it lies in the normal physiological range of the ionic strength of the blood.
Patent AT-E250168-T1 (AT)
Inventor: KORTMANN KARL
IPC: E01C5/00
Filed: 1999-08-07
Granted: 2003-10-15
Abstract: The invention relates to a concrete element that is placed in fluid-tight coverings of useful surfaces, especially in the form of a paving stone, wall element, concrete slab or the like. When said element is placed, at least one of its lateral surfaces borders on one sealing joint. The concrete element is manufactured with at least one preliminary reinforced adhering layer on parts of each side surface facing the sealing joint.
Patent AT-E214477-T1 (AT)
Inventor: GOEBEL EICKHART
IPC: G01M1/16
Filed: 1999-08-30
Granted: 2002-03-15
Abstract: A device for measuring forces generated by unbalance of a rotor, in particular a motor vehicle wheel, includes a stationary frame, an intermediate frame positioned radially within the stationary frame, and first levers supporting the intermediate frame on the stationary frame. The first levers are arranged along imaginary lines that are either parallel to each other or intersect at a first virtual mounting position. A pivot bearing is supported on the intermediate frame by second levers, which are arranged along imaginary lines that intersect at a second virtual mounting position. Mounted coaxially in the pivot bearing is a measuring shaft, which is rotatable about a common axis of the measuring shaft and the pivot bearing. An outer force sensor measures displacement between the intermediate frame and the stationary frame. An inner force sensor measures displacement between the pivot bearing and the intermediate frame.
Patent AT-E239132-T1 (AT)
Inventor: HOLLMARK HOLGER
IPC: D21F9/00
Filed: 1999-09-29
Granted: 2003-05-15
Abstract: Method of producing paper having a three-dimensional pattern of alternating raised and recessed portions which is given the paper in connection with impulse drying, at which the wet paper web is passed through at least one press nip (12) comprising a rotatable roll (13) which is heated and that the paper web when passing through the press nip is given a three-dimensional pattern either by means of a pattern wire (11) and/or by the fact that the heated roll (13) is provided with a three-dimensional pattern, and where the wet paper web (10) before entering said press nip (12) is given a basis weight variation in a non-random pattern.
Patent AT-E294452-T1 (AT)
Inventor: SENGUPTA LOUISE C
IPC: H01G7/00
Filed: 1999-11-04
Granted: 2005-05-15
Abstract: A voltage tunable dielectric varactor includes a tunable ferroelectric layer and first and second non-tunable dielectric layers. First and second electrodes positioned adjacent to the tunable ferroelectric layer form a tunable capacitor. A third electrode is positioned adjacent to the first non-tunable dielectric layer such that the third and first electrodes and the first non-tunable dielectric layer form a first blocking capacitor. A fourth electrode is positioned adjacent to the second non-tunable dielectric layer such that the fourth and second electrodes and the second non-tunable dielectric layer form a second blocking capacitor.
Patent AT-E234321-T1 (AT)
Inventor: LEE TAE SUK
IPC: C07H1/00
Filed: 1999-11-24
Granted: 2003-03-15
Abstract: An erythromycin A 9-O-benzodithiol oxime intermediate represented by the following formula (III) useful for synthesis of clarthromycin and crystalline solvate thereof:Wherein, Y1 and Y2 are independently a hydrogen atoms or trimethylsilyl groups. And, a process for the preparation of clarithromycin using the erythromycin A 9-O-benzodithiol oxime intermediate as described in the specification.
Patent AT-E305548-T1 (AT)
Inventor: GALE KENNETH RONALD
IPC: E04F10/04
Filed: 1999-12-15
Granted: 2005-10-15
Abstract: A support for an awning (10) comprises a plurality of inner members (28), each being pivotally connected to adjacent ones of the inner members (28). Support members (16), the are strengthened by braces (36) extend outwardly from the inner members (28). An awning material, such as shade cloth or canvas, is supported by the support members (16). The support is fixed to a wall (12) or a pole. The support can move between a retracted position in which the support members (16) lie adjacent to each other and an extend position in which distal ends of the support members are spaced from each other. The awning is compact when in the retracted position and aesthetically pleasing.
Patent AT-E235429-T1 (AT)
Inventor: BRUNELOT PIERRE
IPC: G21F9/30
Filed: 1999-12-01
Granted: 2003-04-15
Abstract: The present invention provides a method of processing organic waste (D) in divided solid and/or liquid form, the method being implemented in a single reactor (1) containing a bath of molten glass (V) surmounted by a gas phase (G), the method comprising incinerating said waste (D) in the presence of oxygen at the surface (S) of said bath of molten glass (V), and in vitrifying said incinerated waste (D) in said bath of molten glass (V). In said method, and in characteristic manner, in addition to the oxygen delivered as oxidizer into said gas phase (G), oxygen is also injected into said bath of molten glass (V) in a quantity that is sufficient to minimize or to avoid any formation of metal within said bath of glass (V); advantageously in a quantity that is sufficient to minimize or to avoid any formation of metal within said bath of glass (V) and also to subject said bath of glass (V) to moderate stirring. The present invention also provides apparatus for processing organic waste (D) in divided solid and/or liquid form by incineration and vitrification, the apparatus being suitable for implementing said method.
Patent DE-03716012-T1 (DE)
Title: An feststoff gebundener radikalbildender aktivator und verwendung zur verbesserung von formulierungen für das chemisch-mechanische polieren
Inventor: SMALL J
IPC: B24B37/04
Filed: 2003-02-11
Abstract: Zusammensetzung
zum chemisch-mechanischen Polieren eines Halbleiter- oder Speicherelement-Substrats,
enthaltend:  ein Fluid, enthaltend mindestens eine Verbindung,
die freie Radikale erzeugt, wobei die mindestens eine Verbindung beim
Kontakt mit mindestens einem Aktivator freie Radikale erzeugt, und
wobei der pH-Wert des Fluids zwischen etwa 1 und etwa 11 beträgt; und  eine
Vielzahl von Partikeln mit einer Oberfläche und mindestens einem mit
der Oberfläche
der Partikel assoziierten Aktivator, wobei der mindestens eine Aktivator
ein anderes Metall als ein Metall der Gruppe IV(B), Gruppe V(B),
oder Gruppe VI(B) enthält,
und wobei das Metall multiple Oxidationsstufen aufweist,  wobei
die Zusammensetzung bei der Verwendung in einem chemisch-mechanischen
Polierverfahren das gewünschte Metall
entfernt, aber keine Defekte oder Ungleichmäßigkeiten hervorruft, aufgrund
derer das Substrat keine weiteren Fabri kationsschritte zur Fertigstellung
eines funktionsfähigen
Halbleiter- oder Speicherelements durchlaufen kann.
Patent DE-96829-T1 (DE)
IPC: G01N21/41
Filed: 1983-06-07
Abstract: The apparatus comprises an opaque screen (8), which is placed between a source and the fibre or preform (7) and has an oblique slit (9) which identifies a plane section of the fibre or preform (7), the index profile of which is determined, and an optical system (10, 11) which forms a near-field image of the beam incident on the fibre or preform and a far-field image of the refracted beam, in two perpendicular directions on a photosensitive element (12). The image is scanned line by line by a television camera the photosensitive element (12) makes part of, and the deflection function and hence the refractive-index profile are obtained from the coordinates of the points with maximum brightness by using a computing system.
Patent DE-610436-T1 (DE)
Inventor: SIMMONDS PETER
IPC: C07K16/00
Filed: 1992-11-20
Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.
Patent DE-804565-T1 (DE)
IPC: C12N15/11
Filed: 1995-06-29
Abstract: Nucleic acid molecules and proteins useful for regulating the expression of genes in eukaryotic cells and organisms are disclosed. The invention provides a transcriptional activator fusion protein which binds to tet operator sequences and stimulates transcription of a tet operator-linked gene in the presence, but not the absence, of tetracycline (or analogue thereof). The invention further provides transcriptional inhibitor fusion proteins which inhibit transcription of a tet operator-linked gene in a regulated manner. In one embodiment, the inhibitor fusion protein binds to tet operator sequences in the absence, but not the presence, of tetracycline (or analogue). In another embodiment, the inhibitor fusion protein binds to tet operator sequences in the presence, but not the absence, of tetracycline (or analogue). The transcriptional activator and inhibitor fusion proteins of the invention can be used in combination to regulate expression of one or multiple tet operator-linked genes. Novel tet operator-containing transcription units which allow for coordinate or independent tetracycline-regulated expression of two or more genes by the transcriptional modulators of the invention are also disclosed. Kits including the components of the regulatory system are also encompassed by the invention. <IMAGE>
Patent ES-2254043-T1 (ES)
Title: Proteinas fluorescentes y cromoproteinas procedentes de especies hidrozoa que no son aequorea y metodos para usarlas.
Inventor: LUKYANOV SERGEI ANATOLIEVICH
IPC: C07K16/18
Filed: 2003-11-05
Abstract: Molécula aislada de ácido nucleico que codifica una proteína fluorescente o una cromoproteína, seleccionada del grupo que consta de: (a) un ácido nucleico que codifica una proteína que comprende la secuencia de aminoácido mostrada en los números de secuencia: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20 ó 22; (b) un ácido nucleico que comprende una secuencia nucleótida mostrada en los números de secuencia: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19 ó 21; (c) un ácido nucleico que se hibrida, bajo condiciones severas, al ácido nucleico de (a) o (b) , descrito anteriormente; (d) un ácido nucleico que codifica una proteína que tiene al menos un 75% de identidad de secuencia con respecto a la secuencia de aminoácido de (a) , descrita anteriormente; (e) un ácido nucleico que tiene al menos un 70% de identidad de secuencia con respecto a la secuencia nucleótida de (b) , descrita anteriormente; (f) un ácido nucleico que codifica una proteína que tiene una sustitución, supresión o inserción de al menos un aminoácidoen la secuencia de aminoácido mostrada en los números de secuencia: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20 ó 22; (g) un derivado o mimético del ácido nucleico de (a) , (b) , (c) , (d) , (e) o (f) , descrito anteriormente; (h) un mutante del ácido nucleico de (a) , (b) , (c) , (d) o (e) , descrito anteriormente; (i) un ácido nucleico diferente del ácido nucleico de (b) , (c) , (d) , (e) , (f) , (g) o (h) , descrito anteriormente, debido a la degeneración del código genético; y (j) un fragmento del ácido nucleico de (a) o (b) , descrito anteriormente.
Patent ES-2025539-T1 (ES)
IPC: G05D23/19
Filed: 1989-02-02
Abstract: The invention relates to a method for inducing an electrical control signal for the functional control of a preparation device which is provided with an electrically heatable boiler with a stirring mechanism inside it for medicinal-therapeutic doses and a preparation device of this type. An electrical signal (UT) representative of the instantaneous temperature of the wall is induced by means of a temperature sensor (SENS) disposed in thermal contact with the wall of the boiler. A second electrical signal (URF or UST) representative of a desired functional temperature is induced by means of a setting device (SET2 or SET3). A comparator (COMP2, COMP3) acting as an on/off controller and possibly provided with a control hysteresis compares the two aforementioned electrical signals and induces an output signal which serves as a binary control signal (UH) providing on/off control for the heating of the boiler. The de-activation time interval ( DELTA taus), which increases constantly from one switching cycle to the next due to the thermal interaction between the wall of the boiler and the dose in the boiler depending on the quantity contained in the boiler, between the de-activation time (taus) and the subsequent re- activation time (tein) of the heating is compared in a timer (TIMER1, TIMER2), which is connected behind the comparator output, with a preset, constant device time interval (tapp). If the de-activation time interval (taus) exceeds the device time interval (tapp), the abovementioned electrical control signal is induced at the output of the timer (TIMER1, TIMER2) to provide functional control of the preparation device. <IMAGE>
Patent CY-1112116-T1 (CY)
Inventor: ALBRECHT JANICE K
IPC: A61P31/20
Filed: 2011-11-01
Abstract: The application discloses a combination for use in a method of treating patients suffering from hepatitis C infection who are treatment naive or who have relapsed from having a negative HCV status.
Patent CY-1113104-T1 (CY)
Title: Νεα σκευασματα εμβολιων
Inventor: PARISOT ALEXIS GUY ANDRE
IPC: A61K39/12
Filed: 2012-09-10
Abstract: Η παρούσα εφεύρεση σχετίζεται με γαλακτώματα ελαίου σε νερό, με τη χρήση τους ως ανοσοενισχυτικά, και με φαρμακευτικές, ανοσολογικές συνθέσεις ή συνθέσεις εμβολίων που μπορούν να περιέχουν τα ίδια. Σε μια εφαρμογή, το γαλάκτωμα ελαίου σε νερό (OAV) μπορεί να περιέχει ένα υδατικό διάλυμα που περιέχει ένα ανοσογόνο, ένα ορυκτέλαιο, μια μη ιοντική λιπόφιλη αιθοξυλιωμένη λιπαρή αλκοόλη και ένα μη ιοντικό υδρόφιλο επιφανειοδραστικό μέσο. Σε μια άλλη εφαρμογή, το γαλάκτωμα ελαίου σε νερό (OAV) μπορεί να περιέχει ένα υδατικό διάλυμα που περιέχει ένα ανοσογόνο, ένα μη ιοντικό λιπόφιλο επιφανειοδραστικό μέσο, ένα ορυκτέλαιο και μια μη ιοντική υδρόφιλη αιθοξυλιωμένη αλκοόλη. Η παρούσα εφεύρεση επίσης περιλαμβάνει μια μέθοδο παρασκευής μιας σύνθεσης εμβολίου με χρήση του άνοσο ενισχυτικού της παρούσας εφεύρεσης, τη σύνθεση εμβολίου που λαμβάνεται με τον τρόπο αυτό και μεθόδους χρήσης.
Patent CY-1116487-T1 (CY)
Title: Παραγοντες συνδεσης αμυλοειδους
Inventor: YANG JERRY
IPC: A61P25/28
Filed: 2015-07-13
Abstract: Παρέχονται ενώσεις και μέθοδοι για την ανίχνευση των αμυλοειδών και θεραπεία ασθενειών που σχετίζονται προς αμυλοειδή συμπεριλαμβανομένης ασθένειας Alzheimer και άλλων σχετικών βασιζόμενων σε αμυλοειδές νευροεκφυλιστικών ασθενειών.
Patent CY-1121029-T1 (CY)
Title: Συνδεσμος επιπεδου εμπροσθιας επιφανειας για μεταφορα ρευστων με εμπροσθια δακτυλιοειδη στεγανοποιηση
Inventor: GATTI GIANMARCO
IPC: F16L37/23
Filed: 2018-10-02
Abstract: Ένα εξάρτημα μεταδόσεως ροής ρευστού (100) περιγράφεται εδώ το οποίο περιλαμβάνει έναν θηλυκό σύνδεσμο επιπέδου εμπρόσθιας επιφάνειας (47) με ένα εμπρόσθιο δακτυλιοειδές σύστημα στεγανοποιήσεως (400) για να προστατευτεί το εξάρτημα αυτό από την εισαγωγή τυχόν ακαθαρσιών, όταν αυτό αποσυνδεθεί, κατά τη διάρκεια του βήματος της συνδέσεως - αποσυνδέσεως καθώς και όταν αυτό συνδεθεί πάνω σε έναν αντίστοιχο αρσενικό σύνδεσμο (48) επιπέδου επιφάνειας.
Patent CY-1123398-T1 (CY)
Title: Συνθεση συνδυασμου
Inventor: ATKINSON HARTLEY CAMPBELL
IPC: A61K31/167
Filed: 2019-07-18
Abstract: Ενδοφλέβια σύνθεση για παροχή ανακούφισης για πόνο ή/και φλεγμονή, η δε σύνθεση έχει συνδυασμό ιμπουπροφαίνης και παρακεταμόλης για απελευθέρωση σε έναν άνθρωπο σε εκάστη δόση: a) περίπου 125 χλστγρ. έως περίπου 175 χλστγρ. ιμπουπροφαίνης σε συνδυασμό με περίπου 475 χλστγρ. έως περίπου 525 χλστγρ. παρακεταμόλης ή b) περίπου 275 χλστγρ. έως περίπου 325 χλστγρ. ιμπουπροφαίνης σε συνδυασμό με περίπου 975 χλστγρ. έως περίπου 1.025 χλστγρ. παρακεταμόλης.
Patent CY-1124037-T1 (CY)
Title: Παρασκευη φορτωμενων με πεπτιδιο μικροσφαιριδιων plga me χαρακτηριστικα ελεγχομενης απελευθερωσης
Inventor: KARAVAS EVANGELOS
IPC: A61K38/31
Filed: 2020-11-09
Abstract: Νέα μέθοδος για την παρασκευή ενέσιμης σύνθεσης μακράς δράσης, που βασίζεται επί βιοαποικοδομήσιμων μικροσφαιριδίων πολυ(D,L-λακτιδίου-συν-γλυκολιδίου), που περιλαμβάνουν δραστικά φαρμακευτικά συστατικά πεπτιδίου.
Patent HR-P20181361-T1 (HR)
Title: Aqueous slurries comprising fine calcium carbonate particles for use in paper coatings
Inventor: BLUVOL GUILLERMO
IPC: D21H21/52
Filed: 2018-08-27
Abstract: The present invention relates to an aqueous slurry comprising natural ground calcium carbonate which has a percentage P 5  by weight of particles having a diameter of less than 5.0 µm of from 98.5 % to 90 %, a percentage P 2  by weight of particles having a diameter of less than 2.0 µm of from 96 % to 80%, wherein the ratio of P 2 /P 5  is from 0.98 to 0.85, and wherein the slurry has a solids content of more than 78 wt%.
Patent SI-1501808-T1 (SI)
Title: Tachykinin receptor antagonists
Inventor: AMEGADZIE ALBERT KUDZOVI
IPC: A61K31/00
Filed: 2003-04-22
Abstract: The present invention relates to selective NK-1 receptor antagonists of Formula (I); or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins
Patent SI-1599300-T1 (SI)
Title: Continuous casting method
Inventor: SOMMERHOFER HUBERT
IPC: B22D11/124
Filed: 2004-02-24
Abstract: The invention concerns the continuous casting of metals of all kinds. <??>The invention is characterised in that liquid metal is used as coolant, especially for direct cooling of the strand. The invention further includes a casting device. <IMAGE>
Patent SI-1858491-T1 (SI)
Title: Sublingual coated tablet
Inventor: OURY PASCAL
IPC: A61K9/28
Filed: 2006-03-20
Abstract: The present invention relates to a fentanyl coated tablet and to the method for the preparation thereof.
Patent SI-1989334-T1 (SI)
Title: Method for cooling metallurgical vessels
Inventor: BAUER PETER
IPC: F27D9/00
Filed: 2007-02-22
Abstract: Metallurgical vessels such as troughs or converters, must be inspected from time to time by personal for maintenance purposes, in particular for equipping with fire-resistant material. In order to make inspection possible, the metallurgical vessel must have time to cool after being switched off which means a considerable time delay in re-starting the vessel. In order to shorten cooling time, the metallurgical vessel has been cooled with a ventilator. However, the cooling performance thereof is not altogether sufficient. According to the invention, the cooling process of metallurgical vessels is accelerated as the metallurgical vessel is impinged upon by a cryogenic cooling agent, for example, liquid or solid carbon dioxide or liquid nitrogen. In a preferred embodiment, the metallurgical vessel is sprayed with a carbon-dioxide snow after being switched off. As a result, the cooling process is considerably accelerated.
Patent SI-2079481-T1 (SI)
Title: Vaccine peptide combinations against cat allergy
Inventor: HAFNER RODERICK PETER
IPC: A61K39/00
Filed: 2008-05-30
Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides.
Patent SI-2796466-T1 (SI)
Title: Humanized antibody molecules specific for IL-31
Inventor: BONDENSGAARD KENT
IPC: C07K16/00
Filed: 2008-12-08
Abstract: The invention provides humanized mouse anti-human IL-31 antibodies and antibody fragments that are capable of binding IL-31 and thereby neutralizing, inhibiting, limiting, or reducing the proinflammatory or pro-pruritic effects of IL-31.